Numinus Wellness Inc. files fiscal 2026 interim reports and seeks revocation of its British Columbia cease trade order

Numinus Wellness Inc. announced that it has filed all quarterly interim financial reports for fiscal year 2026, covering the period through May 31, 2026. The filings follow completion of the August 31, 2025 audit and are intended to place the company in a position to satisfy the regulatory requirements needed for the British Columbia Securities Commission to revoke its current cease trade order. Management will also continue its previously announced application to list the company’s common shares on the Canadian Securities Exchange. Numinus describes itself as a mental health care company focused on innovative behavioral health treatments, including safe, evidence-based psychedelic-assisted therapies. The supplied material does not provide details about the financial results, the status of the listing application, or the expected timing of the order’s revocation.